Publications by authors named "F Foroudi"

Purpose: Acute radiation dermatitis (ARD) is a notable challenge for patients with breast cancer undergoing postmastectomy radiation therapy (RT). This study evaluates the efficacy, safety, and user experience of StrataXRT versus Mepitel Film for ARD prevention.

Methods And Materials: This multicenter, noninferiority trial involved intrapatient randomization of 44 patients with histologically confirmed breast carcinoma who had undergone postmastectomy RT across 4 Australian hospitals from January 1 to December 31, 2017.

View Article and Find Full Text PDF

Background: Over the past decade, the adoption of screening programs, digital mammography, and magnetic resonance imaging (MRI) has increased early-stage breast cancer diagnosis rates. Mortality rates have decreased due to early detection and improved treatments, including personalized therapies. Accelerated partial-breast irradiation (APBI) is emerging as a convenient and effective treatment for some patients, with studies exploring its preoperative use.

View Article and Find Full Text PDF

Background And Objective: Delivering radiotherapy to the bladder is challenging as it is a mobile, deformable structure. Dose-escalated adaptive image-guided radiotherapy could improve outcomes. RAIDER aimed to demonstrate the safety of such a schedule.

View Article and Find Full Text PDF

Background: Accelerated partial breast irradiation (APBI) is an accepted treatment option for early breast cancer. Treatment delivered on the Magnetic Resonance integrated Linear Accelerator (MRL) provides the added assurance of improved soft tissue visibility, important in the delivery of APBI. This technique can be delivered in both the supine and prone positions, however current literature suggests that prone treatment on the MRL is infeasible due to physical limitations with bore size.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the safety and effectiveness of stereotactic ablative body radiotherapy (SABR) for re-treating spinal metastases that had previously received radiotherapy.
  • It analyzed data from patients at three Australian centers, focusing on local control rates and serious complications over a median follow-up of 2.6 years.
  • Results showed that the majority of patients had good tumor control and survival rates, suggesting that SABR is a viable option for patients with persistent spinal issues after previous treatments.
View Article and Find Full Text PDF